Aim: An intra-buccal acrylic bioadhesive device designated for drug programmed release that can stay adhered to dental enamel, and also on removable prosthetic restorations, with preventive and/or therapeutic purpose for a large clinical applications based on polymethyl methacrylate/methyl methacrylate/2 hydroxyethyl methacrylate (PMMA/MMA/HEMA) was developed, using the sodium fluoride as an active principle. This bioadhesive was evaluated for its shear bond strength when bonded with different adhesive systems.
Methods: Two substrates (recently extracted human teeth and acrylic prosthesis basis) were used to obtain the 96 test-specimens. Four adhesive systems (Cyanoacrylate ester, 3M Concise Enamel Bond Resin with or without previous enamel etching, MMA/HEMA or PMMA/MMA/ HEMA) were chosen for the fixation of the bioadhesives to substrate. Artificial saliva or distilled water was used as medium for maintaining the specimens until test.
Results: Statistical analysis showed that the interaction bioadhesives/acrylic prosthesis basis/cyanoacrylate ester adhesive was the most resistant to the physical removal by shearing.
Conclusion: The newly rounded semi-convex format of acrylic device developed in this study presented satisfactory shear bond strength and might contribute to the comfort of intra-buccal use.